154 related articles for article (PubMed ID: 31363481)
1. Female genital tract metastasis of lung adenocarcinoma with EGFR mutations: Report of two cases.
Yan RL; Wang J; Zhou JY; Chen Z; Zhou JY
World J Clin Cases; 2019 Jun; 7(12):1515-1521. PubMed ID: 31363481
[TBL] [Abstract][Full Text] [Related]
2. Endometrial metastasis of lung adenocarcinoma: a report of two cases.
Ahmad Z; Raza A; Patel MR
Am J Case Rep; 2015 May; 16():296-9. PubMed ID: 25981989
[TBL] [Abstract][Full Text] [Related]
3. EGFR mutation L747P led to gefitinib resistance and accelerated liver metastases in a Chinese patient with lung adenocarcinoma.
Yu G; Xie X; Sun D; Geng J; Fu F; Zhang L; Wang H
Int J Clin Exp Pathol; 2015; 8(7):8603-6. PubMed ID: 26339441
[TBL] [Abstract][Full Text] [Related]
4. Metastasis of extra-ampullary duodenal adenocarcinoma to the uterine cervix.
Takahashi K; Yoshida H; Watanabe R; Ishikawa M; Ikeda SI; Kato T
Malays J Pathol; 2016 Apr; 38(1):45-8. PubMed ID: 27126664
[TBL] [Abstract][Full Text] [Related]
5. A multicenter phase II study to evaluate the efficacy and safety of gefitinib as first-line treatment for Korean patients with advanced pulmonary adenocarcinoma harboring EGFR mutations.
Kim DW; Lee SH; Lee JS; Lee MA; Kang JH; Kim SY; Shin SW; Kim HK; Heo DS
Lung Cancer; 2011 Jan; 71(1):65-9. PubMed ID: 20430469
[TBL] [Abstract][Full Text] [Related]
6. Tumor-to-tumor metastasis: lung adenocarcinoma metastasizing to a follicular variant of papillary thyroid carcinoma.
Hashimoto K; Yamamoto H; Nakano T; Oyama M; Shiratsuchi H; Nakashima T; Tamiya S; Komune S; Oda Y
Pathol Int; 2011 Jul; 61(7):435-41. PubMed ID: 21707848
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of Consistency in detection of epidermal growth factor receptor gene T790M mutation in plasma and tumor specimens of patients with lung adenocarcinoma].
Du J; Wang Z; Yang L; Di J; Zhang JG; Wang TY; Liu DG
Zhonghua Zhong Liu Za Zhi; 2018 Jan; 40(1):35-39. PubMed ID: 29365415
[No Abstract] [Full Text] [Related]
8. Clinical outcomes of EGFR-TKI treatment and genetic heterogeneity in lung adenocarcinoma patients with EGFR mutations on exons 19 and 21.
Yu JY; Yu SF; Wang SH; Bai H; Zhao J; An TT; Duan JC; Wang J
Chin J Cancer; 2016 Mar; 35():30. PubMed ID: 27001083
[TBL] [Abstract][Full Text] [Related]
9. [Thyroid transcription factor-1 level is associated with epidermal growth factor receptor mutation status in patients with advanced lung adenocarcinoma].
Niu Y; Wang H; Zhang G; Ma J; Wei B; Ma Z
Zhonghua Jie He He Hu Xi Za Zhi; 2014 Dec; 37(12):919-23. PubMed ID: 25609130
[TBL] [Abstract][Full Text] [Related]
10. Case report: small cell transformation and metastasis to the breast in a patient with lung adenocarcinoma following maintenance treatment with epidermal growth factor receptor tyrosine kinase inhibitors.
Lin Q; Cai GP; Yang KY; Yang L; Chen CS; Li YP
BMC Cancer; 2016 Aug; 16():593. PubMed ID: 27488410
[TBL] [Abstract][Full Text] [Related]
11. Adenocarcinoma of the lung with rare insertion mutation in EGFR exon 19 that had partial response to gefitinib: a case report.
Kozlov V; Karpov I; Kovalenko S; Shamanin V
Exp Oncol; 2017 Jul; 39(2):155-156. PubMed ID: 29483495
[TBL] [Abstract][Full Text] [Related]
12. Endometrial metastasis of lung adenocarcinoma: a case report.
Tiseo M; Bersanelli M; Corradi D; Bartolotti M; Gelsomino F; Nizzoli R; Barili MP; Ardizzoni A
Tumori; 2011; 97(3):411-4. PubMed ID: 21789025
[TBL] [Abstract][Full Text] [Related]
13. Sarcomatous transformation of EGFR and TP53 mutation-positive metastatic adenocarcinoma of the lungs, masquerading as a primary pleomorphic sarcoma of the proximal femur.
Toda-Ishii M; Akaike K; Kurisaki-Arakawa A; Arakawa A; Mukaihara K; Suehara Y; Takagi T; Kaneko K; Yao T; Saito T
Int J Clin Exp Pathol; 2015; 8(3):3270-8. PubMed ID: 26045851
[TBL] [Abstract][Full Text] [Related]
14. Detection of epidermal growth factor receptor and human epidermal growth factor receptor 2 activating mutations in lung adenocarcinoma by high-resolution melting amplicon analysis: correlation with gene copy number, protein expression, and hormone receptor expression.
Willmore-Payne C; Holden JA; Layfield LJ
Hum Pathol; 2006 Jun; 37(6):755-63. PubMed ID: 16733218
[TBL] [Abstract][Full Text] [Related]
15. Cytokeratin 7-positive/cytokeratin 20-negative cecal adenocarcinoma metastatic to the uterine cervix: a case report.
Toyoshima M; Momono Y; Makino H; Kudo T; Oka N; Sakurada J; Suzuki H; Kodama H; Yoshinaga K
World J Surg Oncol; 2016 Jan; 14(1):22. PubMed ID: 26810414
[TBL] [Abstract][Full Text] [Related]
16. Thyroid transcription factor-1 as a prognostic indicator for stage IV lung adenocarcinoma with and without EGFR-sensitizing mutations.
Park JY; Jang SH; Kim HI; Kim JH; Park S; Hwang YI; Jung KS; Seo J; Lee CY; Ko Y; Park YB
BMC Cancer; 2019 Jun; 19(1):574. PubMed ID: 31196060
[TBL] [Abstract][Full Text] [Related]
17. Identification of EGFR Mutations by Immunohistochemistry with EGFR Mutation-Specific Antibodies in Biopsy and Resection Specimens from Pulmonary Adenocarcinoma.
Kim CH; Kim SH; Park SY; Yoo J; Kim SK; Kim HK
Cancer Res Treat; 2015 Oct; 47(4):653-60. PubMed ID: 25687872
[TBL] [Abstract][Full Text] [Related]
18. Case report of three EGFR TKI naïve lung adenocarcinoma containing double EGFR mutations (L858R/T790M or Exon 19 Deletion/T790M); Comparing genetic information and histology.
Sakashita S; Shiba-Ishii A; Murata Y; Sekimoto R; Minami Y; Sato Y; Noguchi M
Pathol Res Pract; 2018 Aug; 214(8):1224-1230. PubMed ID: 29887244
[TBL] [Abstract][Full Text] [Related]
19. Comparing the effects of afatinib with gefitinib or Erlotinib in patients with advanced-stage lung adenocarcinoma harboring non-classical epidermal growth factor receptor mutations.
Shen YC; Tseng GC; Tu CY; Chen WC; Liao WC; Chen WC; Li CH; Chen HJ; Hsia TC
Lung Cancer; 2017 Aug; 110():56-62. PubMed ID: 28676220
[TBL] [Abstract][Full Text] [Related]
20. Lung adenocarcinoma harboring rare epidermal growth factor receptor L858R and V834L mutations treated with icotinib: A case report.
Zhai SS; Yu H; Gu TT; Li YX; Lei Y; Zhang HY; Zhen TH; Gao YG
World J Clin Cases; 2020 Sep; 8(17):3841-3846. PubMed ID: 32953862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
